MPO and irritable bowel syndrome: In this study, we aimed to extend our previous work on fecal myeloperoxidase in a prospectively recruited cohort of patients with IBD who had endoscopic evaluation.3 Using this cohort of patients, we have now evaluated measures of fecal myeloperoxidase enzyme activity as noninvasive biomarkers of inflammation.